PPA
CRDL

Painted Porch Advisors’s Cardiol Therapeutics CRDL Stock Holding History

Painted Porch Advisors’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-147
Closed -$157 – 138
2025
Q3 		$157 Hold
147
– – ﹤0.01% 463
2025
Q2 		$200 Hold
147
– – ﹤0.01% 455
2025
Q1 		$143 Sell
147
-353
-71% -$433 ﹤0.01% 516
2024
Q4 		$640 Hold
500
– – ﹤0.01% 460
2024
Q3 		$990 Hold
500
– – ﹤0.01% 371
2024
Q2 		$1.01K Buy
+500
New +$1.06K ﹤0.01% 346

Other funds holding CRDL

TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Painted Porch Advisors's CRDL Position: Q4 2025 in Review

Painted Porch Advisors sold out of Cardiol Therapeutics (CRDL) in Q4 2025, closing a stake of 147 shares — an estimated $157 sold.

Painted Porch Advisors first reported a position in CRDL in Q2 2024 and held it in 6 quarters. The position peaked at $1.01K in Q2 2024. 41 funds tracked by Wall St. Rank hold CRDL as of Q4 2025.

  • Painted Porch Advisors reported no remaining Cardiol Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Painted Porch Advisors sold 147 Cardiol Therapeutics shares in Q4 2025, an estimated $157.
  • Painted Porch Advisors first reported a position in Cardiol Therapeutics in Q2 2024 and held it in 6 quarters.
  • Painted Porch Advisors's Cardiol Therapeutics position peaked at $1.01K in Q2 2024.
  • 41 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q4 2025.

Based on Painted Porch Advisors's 13F filing for Q4 2025, filed 19 Mar 2026.